Use of Vaccines to Prevent Meningitis in Persons with Cochlear Implants

What You Should Know

Pneumococcal Recommendations by Age and Vaccination History

CDC recommends pneumococcal conjugate vaccine (PCV13) for people who have or are candidates for cochlear implants. CDC also recommends pneumococcal polysaccharide vaccine (PPSV23) for people 2 years and older who have or are candidates for cochlear implants. Administer all recommended doses of PCV13 first and then administer PPSV23 according to ACIP recommendations:

See Pneumococcal Vaccination: Summary of Who and When to Vaccinate for more detail.

Other Vaccines Can Help Protect against Meningitis

  • Vaccines are available in the United States that can help protect against most of the bacteria that cause meningitis:
    • 13-valent pneumococcal conjugate (PCV13) (Prevnar 13®)
    • 23-valent pneumococcal polysaccharide (PPSV23) (Pneumovax®)
    • Haemophilus influenzae type b conjugate (Hib) (ActHIB®, Hiberix®, PedvaxHIB®, and Pentacel®)
    • Meningococcal conjugate (Menactra® and Menveo®)
    • Serogroup B meningococcal (Bexsero® and Trumenba®)
  • There is no evidence that people with cochlear implants are more likely to get meningococcal meningitis (caused by Neisseria meningitidis) than people without cochlear implants.
  • See Vaccine-specific ACIP Recommendations for information about how, when, and which pneumococcal and meningococcal vaccines can be given together.

 Top of Page

For More Information

References

 Top of Page

Page last reviewed: May 19, 2017